Today, the Honourable Mark Holland, Canada's Minister of Health, and the Honourable John Main, Nunavut's Minister of Health, announced a bilateral agreement investing over $7.3 million over three ...

The facility incorporates best practices and insights from across the company’s manufacturing division network.

In Canada, 1 in 12 people live with a rare disease, and for most people affected, the cost of treatment is unaffordable. Canadians deserve a health care system that provides timely access to quality ...

Patients in England and Wales with a rare genetic disorder will soon be able to access treatment with MSD's Welireg via the NHS, nearly a year after their counterparts in Scotland. In final draft ...

The team are now recruiting patients into a new trial called LITESPARK-022 that combines Keytruda with MSD’s HIF-2 inhibitor Welireg (belzutifan) as an adjuvant treatment for RCC. Welireg was ...

Health Canada has authorized Welireg to treat von Hippel-Lindau (VHL) disease in adults, an inherited genetic condition associated with tumours developing in multiple organs. For the estimated 774 to ...

After hours report provides a review of the day’s stock market and treasury market session performance with a recap of indices, sector, and industry performance, trends, as well as key news items that ...

Health care systems that adopted a higher volume of telehealth services less frequently used several low-value screening and diagnostic tests, according to results of a cohort study published in ...